Literature DB >> 3126814

Reductive methylation of lysine residues in acidic fibroblast growth factor: effect on mitogenic activity and heparin affinity.

J W Harper1, R R Lobb.   

Abstract

Reductive methylation of bovine brain derived acidic fibroblast growth factor (aFGF) with formaldehyde and sodium cyanoborohydride reduces its capacity to stimulate mitogenesis in Balb/C 3T3 cells, and this correlates with the modification of less than 3 of its 12 lysine residues. Fractionation of methylated aFGF on immobilized heparin shows that the affinity of the modified mitogen for heparin is also decreased substantially. The capacity of methylated mitogen of low heparin affinity (LA-aFGF) to stimulate mitogenesis is also reduced, and this correlates with a reduced affinity for its cell surface receptor. Structural characterization of LA-aFGF using peptide mapping and sequencing procedures demonstrates that Lys-118 is the primary site of modification. The results indicate that in aFGF, Lys-118 plays an important role in heparin binding and suggest that this residue and its local environment are involved in the interaction of aFGF with both heparin and its cell surface receptor.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3126814     DOI: 10.1021/bi00402a027

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  11 in total

1.  Gentisic acid, a compound associated with plant defense and a metabolite of aspirin, heads a new class of in vivo fibroblast growth factor inhibitors.

Authors:  Israel S Fernández; Pedro Cuevas; Javier Angulo; Pilar López-Navajas; Angeles Canales-Mayordomo; Rocío González-Corrochano; Rosa M Lozano; Serafín Valverde; Jesús Jiménez-Barbero; Antonio Romero; Guillermo Giménez-Gallego
Journal:  J Biol Chem       Date:  2010-02-09       Impact factor: 5.157

2.  SH2B1β interacts with STAT3 and enhances fibroblast growth factor 1-induced gene expression during neuronal differentiation.

Authors:  Yu-Jung Chang; Kuan-Wei Chen; Ching-Jen Chen; Ming-Hsing Lin; Yuh-Ju Sun; Jia-Lin Lee; Ing-Ming Chiu; Linyi Chen
Journal:  Mol Cell Biol       Date:  2014-01-06       Impact factor: 4.272

3.  Three-dimensional structure of human basic fibroblast growth factor.

Authors:  A E Eriksson; L S Cousens; L H Weaver; B W Matthews
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

4.  Three-dimensional structure of human basic fibroblast growth factor, a structural homolog of interleukin 1 beta.

Authors:  J D Zhang; L S Cousens; P J Barr; S R Sprang
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

5.  Isolation of peptides that inhibit binding of basic fibroblast growth factor to its receptor from a random phage-epitope library.

Authors:  A Yayon; D Aviezer; M Safran; J L Gross; Y Heldman; S Cabilly; D Givol; E Katchalski-Katzir
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

6.  Refinement of the structure of human basic fibroblast growth factor at 1.6 A resolution and analysis of presumed heparin binding sites by selenate substitution.

Authors:  A E Eriksson; L S Cousens; B W Matthews
Journal:  Protein Sci       Date:  1993-08       Impact factor: 6.725

7.  Experimental support for the foldability-function tradeoff hypothesis: segregation of the folding nucleus and functional regions in fibroblast growth factor-1.

Authors:  Liam Longo; Jihun Lee; Michael Blaber
Journal:  Protein Sci       Date:  2012-11-06       Impact factor: 6.725

8.  Investigating the dynamics and polyanion binding sites of fibroblast growth factor-1 using hydrogen-deuterium exchange mass spectrometry.

Authors:  Siva K Angalakurthi; Connie A Tenorio; Michael Blaber; Charles Russell Middaugh
Journal:  Protein Sci       Date:  2018-05-03       Impact factor: 6.725

9.  Possible dissociation of the heparin-binding and mitogenic activities of heparin-binding (acidic fibroblast) growth factor-1 from its receptor-binding activities by site-directed mutagenesis of a single lysine residue.

Authors:  W H Burgess; A M Shaheen; M Ravera; M Jaye; P J Donohue; J A Winkles
Journal:  J Cell Biol       Date:  1990-11       Impact factor: 10.539

10.  Increased protein stability of FGF1 can compensate for its reduced affinity for heparin.

Authors:  Malgorzata Zakrzewska; Antoni Wiedlocha; Anna Szlachcic; Daniel Krowarsch; Jacek Otlewski; Sjur Olsnes
Journal:  J Biol Chem       Date:  2009-07-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.